Lab
Biomed Lab
Biomed Lab was paid $50K by Medicaid between Apr 2022 and Nov 2024, across 40 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 39% of everything it billed.
33Billing provider infoBIOMED LAB
GLENDALE, CA 91204
GLENDALE, CA 91204
33aNPI1770245151assigned 10/12/2021
33bProvider typeClinical Medical Laboratory
28Total paid$50K
24GClaims20,503
24DCodes billed40
24AFirst – last monthApr 2022 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#364 of 561
Median peer was paid$222K
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 2,004 | $12K | |
| 2023 | 5,921 | $11K | |
| 2024incomplete | 12,578 | $27K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 39% | 1,070 | 1,063 | $19K |
| 87631 | 7.4% | 714 | 711 | $4K | |
| 87486 | 3.9% | 690 | 687 | $2K | |
| 87541 | 3.1% | 689 | 687 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.9% | 645 | 639 | $1K |
| 80061 | Lipid panel | 2.8% | 624 | 619 | $1K |
| 82746 | 2.7% | 631 | 625 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.7% | 398 | 396 | $1K |
| 84480 | 2.6% | 652 | 646 | $1K | |
| 82607 | 2.5% | 544 | 538 | $1K | |
| 86677 | 2.5% | 584 | 579 | $1K | |
| 82728 | 2.4% | 664 | 657 | $1K |
28 more codes
| 80053 | Comprehensive metabolic panel | 2.3% | 689 | $1K |
| 87581 | 2.1% | 663 | $1K | |
| 86038 | 1.8% | 554 | $886.54 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.5% | 609 | $736.16 |
| 84439 | 1.5% | 665 | $731.16 | |
| 82150 | 1.4% | 701 | $704.78 | |
| 87481 | 1.4% | 363 | $691.98 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 641 | $629.46 |
| 83735 | 1.2% | 656 | $601.83 | |
| 84100 | 1.2% | 674 | $586.77 | |
| 83540 | 1.1% | 642 | $565.64 | |
| 86430 | 1.1% | 669 | $536.10 | |
| 82248 | 1.0% | 701 | $517.46 | |
| 84550 | <1% | 635 | $475.40 | |
| 86140 | <1% | 655 | $427.66 | |
| 85651 | <1% | 639 | $376.12 | |
| 87641 | <1% | 380 | $374.82 | |
| 87653 | <1% | 380 | $372.46 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 363 | $324.77 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 363 | $323.73 |
| 87640 | <1% | 306 | $317.92 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 361 | $312.14 |
| 82378 | <1% | 128 | $91.00 | |
| 84153 | <1% | 82 | $70.25 | |
| 84403 | <1% | 26 | $50.58 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 13 | $26.75 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 27 | $0.00 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBASEER, AHSAN (AUTHORIZED PERSONNEL)
| Provider | Location | Paid |
|---|---|---|
| PRG Technologies, INC | Anaheim, CA | $5.85M |
| Nbio Lab INC | Burbank, CA | $78K |
| Tekotest Lab INC | Burbank, CA | $48K |
| L&G Laboratory INC | Van Nuys, CA | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.